76413-154 : Coartem Oral Tablet


NDC76413-154
Labeler: Central Texas Community Health Centers
Product Type: Human Prescription Drug
Drug Name:  Coartem
Dosage Form: Oral Tablet
Application #: NDA022268
Rev. Date: 


Appearance:


Markings: N;C;CG
Shapes:  Round
Colors:  Yellow
Size (mm): 9
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

N C CG: (0078-0568) Coartem Oral Tablet by Central Texas Community Health Centers
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 76413-154-06: 6 TABLET IN 1 BOTTLE, PLASTIC (76413‑154‑06)
  • 76413-154-12: 12 TABLET IN 1 BOTTLE, PLASTIC (76413‑154‑12)
  • 76413-154-18: 18 TABLET IN 1 BOTTLE, PLASTIC (76413‑154‑18)
  • 76413-154-24: 24 TABLET IN 1 BOTTLE, PLASTIC (76413‑154‑24)

Active Ingredients:

  • Artemether
  • Lumefantrine

Dosage Strength:

  • 20 mg
  • 120 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Croscarmellose Sodium
  • Hypromellose, Unspecified
  • Magnesium Stearate
  • Microcrystalline Cellulose
  • Polysorbate 80

Pharmaceutical Classes:

  • Antimalarial [EPC]

Related Products:

Based on records with the same trade name.
  • 0078-0568 Coartem (Artemether 20 mg / Lumefantrine 120 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 55695-020 Coartem Oral Tablet by Department of State Health Services, Pharmacy Branch

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 76413-154 QR Code

< Prev: 76413-153Next: 76413-155 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.